MedPath

Prospective Validation of Radiomics models for evaluation of molecular biomarkers in patients with cerebral metastasis

Conditions
C79.3
Secondary malignant neoplasm of brain and cerebral meninges
Registration Number
DRKS00032787
Lead Sponsor
Zentrum für Neurochirurgie, Universitätsklinik Köln, Universität zu Köln
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
200
Inclusion Criteria

brain metastasis
available preoperative MRI
interdiciplinary tumor board decision for surgery or biopsy of the brain metastasis

Exclusion Criteria

Previous local therapy for brain metastases

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Validation of Radiomics models for prediction of molecular biomarkers in patients with brain metastases.
Secondary Outcome Measures
NameTimeMethod
Evaluation of the biological meaning of the acquired radiomics signatures.
© Copyright 2025. All Rights Reserved by MedPath